Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double-blind, Placebo-controlled, Dose-ranging Phase II Study of APD421 for the Prevention of Post-operative Nausea and Vomiting

NCT01510704 is registered in ClinicalTrials.gov with Acacia Pharma Ltd as lead sponsor.

NCT NCT01510704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01510704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double-blind, Placebo-controlled, Dose-ranging Phase II Study of APD421 for the Prevention of Post-operative Nausea and Vomiting
Lead sponsor
Acacia Pharma Ltd
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
April 30, 2012
Enrollment
215 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative nausea and vomiting